Biologics Supplier for Orthopedic Practices in Tucson, AZ

Vendor Qualification for Orthopedic Groups

Orthopedic practices and ambulatory surgery centers that bring in a new biologics vendor generally start the same way: a documentation request before a purchase order. That typically means a certificate of analysis for the specific lot, a donor eligibility summary describing the screening and serology testing performed at the time of donation, and a record of the third-party sterility testing each lot passes before it is released from quarantine.

Precision Biologics provides this documentation on request to verified accounts. We do not publish lot-specific numbers on this site, because they vary by lot and are confirmed on the certificate that ships with the product.

Setting Up an NPI-Verified Account

Orders are limited to licensed physicians and to clinics operating under physician supervision. Opening an account requires an NPI number, which we use to confirm that the practice is an active, licensed provider before any order is processed.

Once an account is open, practices can request a peer-to-peer call to go over product documentation, processing descriptions, and testing records with someone on our side. These calls are limited to documentation and procurement questions; they are not a substitute for a physician's own clinical or regulatory judgment.

Cold Chain and Receiving

Cryopreserved Wharton's jelly products are slow-rate frozen, stored at -80 degrees C, and shipped overnight on dry ice inside validated shipping containers. Receiving staff should be ready to move the shipment into appropriate storage as soon as it arrives rather than letting it sit at the loading dock.

Each lot is tracked at the patient record level once it reaches the clinic, which gives the practice a traceable chain from donation lot to the patient the product was used with.

Confirming Where a Product Fits Your Regulatory Picture

Whether a given use of a Wharton's jelly product is minimally manipulated and for homologous use under 21 CFR 1271.10, or whether an exosome product's intended use fits a practice's existing regulatory posture, is a determination for the practice and its own counsel, not something Precision Biologics advises on. Exosome products are generally regulated as biologic drugs, and FDA has stated that no exosome product currently holds FDA approval.

Before adding any new biologics line, we recommend practices confirm standing with the Arizona Medical Board or the Arizona Board of Osteopathic Examiners as applicable, in addition to their own legal counsel. These products are not FDA approved or licensed for any disease or condition; this page is written for licensed healthcare professionals and is not medical or legal advice.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.